메뉴 건너뛰기




Volumn 24, Issue 2, 2011, Pages 323-335

Anti-TNF-α antibody (infliximab) therapy supports the recovery of enos and VEGFR2 protein expression in endothelial cells

Author keywords

Crohn's disease; eNOS; HUVEC; Inflammatory bowel disease; Infliximab; TNF ; Vascular endothelial growth factor receptor 2

Indexed keywords

AZATHIOPRINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INFLIXIMAB; MESALAZINE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 2; ANGIOGENIN; ANTIINFLAMMATORY AGENT; FIBROBLAST GROWTH FACTOR 2; MONOCLONAL ANTIBODY; NOS3 PROTEIN, HUMAN; PANCREATIC RIBONUCLEASE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

EID: 80051733035     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400206     Document Type: Article
Times cited : (17)

References (30)
  • 1
    • 77956499693 scopus 로고    scopus 로고
    • Innate antimicrobial immunity in inflammatory bowel diseases
    • Beisner J, Stange EF, Wehkamp J. Innate antimicrobial immunity in inflammatory bowel diseases. Expert Rev Clin Immunol 2010; 6:809-18.
    • (2010) Expert Rev Clin Immunol , vol.6 , pp. 809-818
    • Beisner, J.1    Stange, E.F.2    Wehkamp, J.3
  • 3
    • 0035487682 scopus 로고    scopus 로고
    • Immunological basis of inflammatory bowel disease: Role of the microcirculation
    • DOI 10.1038/sj.mn.7800095
    • Laroux FS, Grisham MB. Immunological basis of inflammatory bowel disease: role of the microcirculation. Microcirculation 2001; 8:283-301. (Pubitemid 33598134)
    • (2001) Microcirculation , vol.8 , Issue.5 , pp. 283-301
    • Laroux, F.S.1    Grisham, M.B.2
  • 6
    • 9344257937 scopus 로고    scopus 로고
    • Increased gut permeability in Crohn's disease: Is TNF the link?
    • DOI 10.1136/gut.2004.047092
    • Gibson PR. Increased gut permeability in Crohn's disease: is TNF the link? Gut 2004; 53:1724-5. (Pubitemid 39556884)
    • (2004) Gut , vol.53 , Issue.12 , pp. 1724-1725
    • Gibson, P.R.1
  • 8
    • 33751537126 scopus 로고    scopus 로고
    • TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells
    • DOI 10.1189/jlb.0905530
    • Viemann D, Goebeler M, Schmid S, Nordhues U, Klimmek K, Sorg C, Roth J. TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells. J Leukoc Biol 2006; 80:174-85. (Pubitemid 44835538)
    • (2006) Journal of Leukocyte Biology , vol.80 , Issue.1 , pp. 174-185
    • Viemann, D.1    Goebeler, M.2    Schmid, S.3    Nordhues, U.4    Klimmek, K.5    Sorg, C.6    Roth, J.7
  • 9
    • 0030331087 scopus 로고    scopus 로고
    • Regulation of nitric oxide synthase gene expression by cytokines
    • Yokoyama M, Hirata K, Kawashima S, Kawahara Y. Regulation of nitric oxide synthase gene expression by cytokines. J Card Fail 1996; 2(S):179-85.
    • (1996) J Card Fail , vol.2 , Issue.S , pp. 179-185
    • Yokoyama, M.1    Hirata, K.2    Kawashima, S.3    Kawahara, Y.4
  • 11
    • 33749318200 scopus 로고    scopus 로고
    • Vascular endothelial growth factor signaling to endothelial nitric oxide synthase: More than a FLeeTing moment
    • DOI 10.1161/01.RES.0000245430.24075.a4, PII 0000301220060929000002
    • Lin MI, Sessa WC. Vascular Endothelial growth factor signaling to endothelial nitric oxide synthase. Circ Res 2006; 99:666-8. (Pubitemid 44498299)
    • (2006) Circulation Research , vol.99 , Issue.7 , pp. 666-668
    • Lin, M.I.1    Sessa, W.C.2
  • 12
    • 0038449206 scopus 로고    scopus 로고
    • Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation
    • DOI 10.1016/S0016-5085(03)00699-1
    • Hatoumi OA, Binion DG, Otterson MF, Gutterman DD. Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 2003; 125:58-69. (Pubitemid 36799107)
    • (2003) Gastroenterology , vol.125 , Issue.1 , pp. 58-69
    • Hatoum, O.A.1    Binion, D.G.2    Otterson, M.F.3    Gutterman, D.D.4
  • 13
    • 20444479801 scopus 로고    scopus 로고
    • Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease
    • Palatka K, Serfocombining double acute accentzocombining double acute accent Z, Veréb Z, et al. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease. Scand J Gastroenterol 2005; 40:670-80.
    • (2005) Scand J Gastroenterol , vol.40 , pp. 670-680
    • Palatka, K.1    Serfozo, Z.2    Veréb, Z.3
  • 14
    • 33645880135 scopus 로고    scopus 로고
    • Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells
    • Palatka K, Serfocombining double acute accentzocombining double acute accent Z, Veréb Z, et al. Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells. World J Gastroenterol 2006; 12:1730-8.
    • (2006) World J Gastroenterol , vol.12 , pp. 1730-1738
    • Palatka, K.1    Serfozo, Z.2    Veréb, Z.3
  • 15
    • 0035072493 scopus 로고    scopus 로고
    • VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: A novel mechanism of chronic intestinal inflammation
    • DOI 10.1016/S0002-9270(00)02320-0, PII S0002927000023200
    • Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 2001; 3:822-8. (Pubitemid 32240738)
    • (2001) American Journal of Gastroenterology , vol.96 , Issue.3 , pp. 822-828
    • Kanazawa, S.1    Tsunoda, T.2    Onuma, E.3    Majima, T.4    Kagiyama, M.5    Kikuchi, K.6
  • 16
    • 0032750425 scopus 로고    scopus 로고
    • Nitric-oxide an endothelial survival factor
    • Dimmeler S, Zeiher AM. Nitric-oxide an endothelial survival factor. Cell Death Differ 1999; 6:964-8.
    • (1999) Cell Death Differ , vol.6 , pp. 964-968
    • Dimmeler, S.1    Zeiher, A.M.2
  • 17
    • 0033125226 scopus 로고    scopus 로고
    • Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety
    • Sandborn WJ, Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis 1999; 5:119-33.
    • (1999) Inflamm Bowel Dis , vol.5 , pp. 119-133
    • Sandborn, W.J.1    Hanauer, S.B.2
  • 18
    • 70449347809 scopus 로고    scopus 로고
    • Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - A Hungarian nationwide observational study
    • Miheller P, Lakatos PL, Horváth G, et al. Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study. BMC Gastroenterol 2009; 9:66.
    • (2009) BMC Gastroenterol , vol.9 , pp. 66
    • Miheller, P.1    Lakatos, P.L.2    Horváth, G.3
  • 23
    • 20444464523 scopus 로고    scopus 로고
    • Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease
    • DOI 10.1136/jcp.2004.021840
    • Sanders DSA. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease. J Clin Pathol 2005; 58:568-72. (Pubitemid 40814012)
    • (2005) Journal of Clinical Pathology , vol.58 , Issue.6 , pp. 568-572
    • Sanders, D.S.A.1
  • 24
    • 0042889191 scopus 로고    scopus 로고
    • Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis
    • Kimura H, Esumi H. Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis Acta Bioch Pol 2003; 50:49-59.
    • (2003) Acta Bioch Pol , vol.50 , pp. 49-59
    • Kimura, H.1    Esumi, H.2
  • 25
    • 77951699944 scopus 로고    scopus 로고
    • Long-term anti-TNF-alpha treatments reverse the endothelial dysfunction in rheumatoid arthritis: The biological coherence between synovial and endothelial inflammation
    • Capria A, De Nardo D, Baffetti FR, Barbini U, Violo A, Tondo T, Fontana L. Long-term anti-TNF-alpha treatments reverse the endothelial dysfunction in rheumatoid arthritis: the biological coherence between synovial and endothelial inflammation. Int J Immunopathol Pharmacol 2010; 23:255-62.
    • (2010) Int J Immunopathol Pharmacol , vol.23 , pp. 255-262
    • Capria, A.1    De Nardo, D.2    Baffetti, F.R.3    Barbini, U.4    Violo, A.5    Tondo, T.6    Fontana, L.7
  • 26
    • 79953797881 scopus 로고    scopus 로고
    • Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease
    • Rutella S, Fiorino G, Vetrano S, et al. Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease. Am J Gastroenterol 2011; 106:762-70.
    • (2011) Am J Gastroenterol , vol.106 , pp. 762-770
    • Rutella, S.1    Fiorino, G.2    Vetrano, S.3
  • 27
    • 0036734321 scopus 로고    scopus 로고
    • High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease
    • Martínez-Borra J, López-Larrea C, González S, et al. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease. Am J Gastroenterol 2002; 97:2350-6.
    • (2002) Am J Gastroenterol , vol.97 , pp. 2350-2356
    • Martínez-Borra, J.1    López-Larrea, C.2    González, S.3
  • 28
    • 53249149631 scopus 로고    scopus 로고
    • Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1
    • Yan G, You B, Chen SP, Liao JK, Sun J. Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1. Circ Res 2008; 103:591-7.
    • (2008) Circ Res , vol.103 , pp. 591-597
    • Yan, G.1    You, B.2    Chen, S.P.3    Liao, J.K.4    Sun, J.5
  • 30
    • 0032555509 scopus 로고    scopus 로고
    • Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells
    • DOI 10.1074/jbc.273.34.22128
    • Giraudo E, Primo L, Audero E, Gerber HP, Koolwijk P, Soker S, Klagsbrun M, Ferrara N, Bussolino F. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J Biol Chem 1998; 273:22128-35. (Pubitemid 28405397)
    • (1998) Journal of Biological Chemistry , vol.273 , Issue.34 , pp. 22128-22135
    • Giraudo, E.1    Primo, L.2    Audero, E.3    Gerber, H.-P.4    Koolwijk, P.5    Soker, S.6    Klagsbrun, M.7    Ferrara, N.8    Bussolino, F.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.